Johnson & Johnson (JNJ) operating KPIs
JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3043% above fair value
$273.20−2.00 (-0.73%)
Close on Oct 30, 2026Market cap $658.38BP/E 31.7Yield 1.88%
Johnson & Johnson u.S. Consumer Price Index (CPI) — Medical Care Commodities (CUSR0000SAM1)
FRED (CUSR0000SAM1)
Latest, Q3 2026
404.94
Period ended Sep 30, 2026
Change on a year earlier
-2.9%
417.00 in Q3 2025
History
42 quarters
Since Q1 2016
Sources
1
FRED (CUSR0000SAM1)
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | U.S. Consumer Price Index (CPI) — Medical Care Commodities (CUSR0000SAM1) | Year on year | Source |
|---|---|---|---|---|
| Q3 2026 | Sep 30, 2026 | 404.94 | -2.9% | FRED (CUSR0000SAM1) ↗ |
| Q2 2026 | Jun 28, 2026 | 410.39 | -1.5% | FRED (CUSR0000SAM1) ↗ |
| Q1 2026 | Mar 29, 2026 | 416.81 | +0.2% | FRED (CUSR0000SAM1) ↗ |
| Q3 2025 | Sep 28, 2025 | 417.00 | +0.3% | FRED (CUSR0000SAM1) ↗ |
| Q2 2025 | Jun 29, 2025 | 416.48 | +0.5% | FRED (CUSR0000SAM1) ↗ |
| Q1 2025 | Mar 30, 2025 | 415.97 | +1.9% | FRED (CUSR0000SAM1) ↗ |
| Q4 2024 | Dec 29, 2024 | 412.57 | +0.6% | FRED (CUSR0000SAM1) ↗ |
| Q3 2024 | Sep 29, 2024 | 415.90 | +2.1% | FRED (CUSR0000SAM1) ↗ |
| Q2 2024 | Jun 30, 2024 | 414.52 | +2.9% | FRED (CUSR0000SAM1) ↗ |
| Q1 2024 | Mar 31, 2024 | 408.35 | +2.8% | FRED (CUSR0000SAM1) ↗ |
| Q4 2023 | Dec 31, 2023 | 410.06 | +4.8% | FRED (CUSR0000SAM1) ↗ |
| Q3 2023 | Oct 1, 2023 | 407.29 | +4.3% | FRED (CUSR0000SAM1) ↗ |
| Q2 2023 | Jul 2, 2023 | 402.74 | +4.2% | FRED (CUSR0000SAM1) ↗ |
| Q1 2023 | Apr 2, 2023 | 397.15 | +3.4% | FRED (CUSR0000SAM1) ↗ |
| Q4 2022 | Jan 1, 2023 | 391.26 | +3.1% | FRED (CUSR0000SAM1) ↗ |
| Q3 2022 | Oct 2, 2022 | 390.60 | +3.8% | FRED (CUSR0000SAM1) ↗ |
| Q2 2022 | Jul 3, 2022 | 386.46 | +2.6% | FRED (CUSR0000SAM1) ↗ |
| Q1 2022 | Apr 3, 2022 | 384.12 | +2.2% | FRED (CUSR0000SAM1) ↗ |
| Q4 2021 | Jan 2, 2022 | 379.37 | +0.1% | FRED (CUSR0000SAM1) ↗ |
| Q3 2021 | Oct 3, 2021 | 376.28 | -2.1% | FRED (CUSR0000SAM1) ↗ |
| Q2 2021 | Jul 4, 2021 | 376.72 | -1.9% | FRED (CUSR0000SAM1) ↗ |
| Q1 2021 | Apr 4, 2021 | 375.85 | -2.4% | FRED (CUSR0000SAM1) ↗ |
| Q4 2020 | Jan 3, 2021 | 379.03 | -1.5% | FRED (CUSR0000SAM1) ↗ |
| Q3 2020 | Sep 27, 2020 | 384.27 | +0.9% | FRED (CUSR0000SAM1) ↗ |
| Q2 2020 | Jun 28, 2020 | 384.16 | +0.9% | FRED (CUSR0000SAM1) ↗ |
| Q1 2020 | Mar 29, 2020 | 385.18 | +1.6% | FRED (CUSR0000SAM1) ↗ |
| Q4 2019 | Dec 29, 2019 | 384.69 | +1.4% | FRED (CUSR0000SAM1) ↗ |
| Q3 2019 | Sep 29, 2019 | 380.78 | -0.2% | FRED (CUSR0000SAM1) ↗ |
| Q2 2019 | Jun 30, 2019 | 380.59 | -0.7% | FRED (CUSR0000SAM1) ↗ |
| Q1 2019 | Mar 31, 2019 | 379.10 | -0.6% | FRED (CUSR0000SAM1) ↗ |
| Q4 2018 | Dec 30, 2018 | 379.50 | +0.3% | FRED (CUSR0000SAM1) ↗ |
| Q3 2018 | Sep 30, 2018 | 381.55 | +0.5% | FRED (CUSR0000SAM1) ↗ |
| Q2 2018 | Jul 1, 2018 | 383.11 | +2.3% | FRED (CUSR0000SAM1) ↗ |
| Q1 2018 | Apr 1, 2018 | 381.54 | +1.6% | FRED (CUSR0000SAM1) ↗ |
| Q4 2017 | Dec 31, 2017 | 378.48 | +1.7% | FRED (CUSR0000SAM1) ↗ |
| Q3 2017 | Oct 1, 2017 | 379.76 | +2.4% | FRED (CUSR0000SAM1) ↗ |
| Q2 2017 | Jul 2, 2017 | 374.35 | +3.0% | FRED (CUSR0000SAM1) ↗ |
| Q1 2017 | Apr 2, 2017 | 375.56 | +4.2% | FRED (CUSR0000SAM1) ↗ |
| Q4 2016 | Jan 1, 2017 | 372.30 | – | FRED (CUSR0000SAM1) ↗ |
| Q3 2016 | Oct 2, 2016 | 371.01 | – | FRED (CUSR0000SAM1) ↗ |
| Q2 2016 | Jul 3, 2016 | 363.40 | – | FRED (CUSR0000SAM1) ↗ |
| Q1 2016 | Apr 3, 2016 | 360.41 | – | FRED (CUSR0000SAM1) ↗ |
Cite this data
StockData. (2026). Johnson & Johnson U.S. Consumer Price Index (CPI) — Medical Care Commodities (CUSR0000SAM1), quarterly Q1 2016–Q3 2026 [Data set]. Compiled from Johnson & Johnson SEC filings and investor materials. https://stockdatahq.com/stocks/jnj/kpis/fred_cpi_med_commodities
See every metric in the Johnson & Johnson KPI table. Data updated Oct 25, 2026.